IP Library Granted Patent US 9,389,218
Granted Patent B2
US 9,389,218 · App. 14/381,635 · Granted Jul 12, 2016

Measuring device, dialysis end condition determining device, and dialysis progress presenting device

Inventors: Mikihiro Yamanaka (Osaka, JP); Keita Hara (Osaka, JP); Ryoji Nagai (Kikuchigun, JP)
Assignees: Sharp Kabushiki Kaisha; Ryoji Nagai
G01N33/4915A61B5/1455A61B5/14546A61M1/14A61M1/367G01N21/6486G01N33/491A61M2205/3313A61M2230/20G01N2201/062G01N2201/06113G01N2201/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,389,218
App. No.
14/381,635
Granted
Jul 12, 2016
Kind
B2
Abstract

A measuring device ( 10 ) includes an analysis unit ( 101 ) that holds a fluid pool (B) of blood or serum therein, an irradiation unit ( 105 ) that irradiates fluorescent substances contained in the fluid pool (B) with excitation light, and a light receiving unit ( 106 ) that receives fluorescence generated from the fluorescent substances. An amount of the fluorescent substances contained in the blood or the serum after artificial dialysis is estimated from the intensity of the fluorescence.

Claims (28)

1. A measuring device comprising:

an analysis unit that holds blood or serum therein;

an irradiation unit that irradiates fluorescent substances in the blood or the serum with excitation light; and

a light receiving unit that receives fluorescence generated upon irradiation with the excitation light, wherein

the analysis unit includes:

an inflow port through which the blood or the serum flows in; and

an outflow port through which the blood or the serum flows out; wherein

when inflow and outflow of the blood or the serum are in an equilibrium state, a fluid pool of the blood or the serum is formed inside the analysis unit;

the analysis unit is a drip chamber;

the fluid pool of the blood or serum is located inside of the drip chamber;

the irradiation unit is positioned outside the drip chamber and irradiates fluorescent substances in the fluid pool with excitation light through a wall of the drip chamber;

the light receiving unit is positioned outside the drip chamber and receives fluorescence in the fluid pool with the excitation light through a portion of the wall of the drip chamber, the portion contacting the fluid pool; and

the blood or the serum is irradiated with the excitation light from the irradiation unit in a direction that is perpendicular to a direction in which the fluorescence is received by the light receiving unit.

2. The measuring device according to claim 1 , wherein the analysis unit includes a hole through which a syringe is inserted to sample the blood or the serum from the fluid pool.

3. The measuring device according to claim 1 , wherein the measuring device obtains the serum through centrifugal separation of the blood.

4. The measuring device according to claim 1 , wherein when the blood or the serum branched from a flow passage, through which the blood or the serum flows at a first flow rate, flows into the analysis unit, the measuring device further comprises a regulator that decelerates the blood or the serum flowing into the analysis unit to a second flow rate.

5. The measuring device according to claim 4 , wherein

the regulator is a needle valve; and

the second flow rate is regulated to be 10 ml/min or less by rotating a needle of the needle valve.

6. The measuring device according to claim 1 , wherein the analysis unit is made of quartz.

7. The measuring device according to claim 1 , wherein the irradiation unit irradiates the fluorescent substances in the blood or the serum with the excitation light having a peak wavelength in a range of 338 to 342 nm; and

the light receiving unit receives the fluorescence having a peak wavelength in a range of 420 to 460 nm.

8. A dialysis end condition determining device including:

the measuring device according to claim 1 ; and

a determination unit that is connected to the measuring device and compares an amount of fluorescent substances, which is estimated from a measurement result of fluorescence intensity obtained by measuring the intensity of fluorescence by the measuring device, with a predetermined reference value, and that determines, based on a comparison result, whether a dialysis end condition is satisfied.

9. A dialysis progress presenting device including:

the measuring device according to claim 1 ; and

a presentation unit that is connected to the measuring device and continuously presents an amount of fluorescent substances, which is estimated from a measurement result of fluorescence intensity obtained by measuring the intensity of fluorescence by the measuring device.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2025
From: AIR WATER BD INC.
To: AIR WATER INC.
Reel/Frame 072125/0813 →
CHANGE OF NAME Recorded Aug 27, 2025
From: AIR WATER BIODESIGN INC.
To: AIR WATER BD INC.
Reel/Frame 072585/0729 →
CHANGE OF NAME Recorded Aug 27, 2025
From: SHARP LIFE SCIENCE CORPORATION
To: AIR WATER BIODESIGN INC.
Reel/Frame 072589/0146 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: SHARP KABUSHIKI KAISHA
To: SHARP LIFE SCIENCE CORPORATION
Reel/Frame 043100/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2014
From: YAMANAKA, MIKIHIRO; HARA, KEITA; NAGAI, RYOJI
To: SHARP KABUSHIKI KAISHA; NAGAI, RYOJI
Reel/Frame 033627/0817 →
Priority Claims (1)
JP 2012-081904 · Mar 30, 2012 · national
Continuity (1)
Related Publication 20150044099A1 · Feb 12, 2015